Patent details

EP2340847 Title: CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES

Basic Information

Publication number:
EP2340847
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP101952687
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES
French Title of Invention:
POPULATIONS DE CELLULES PRESENTANT UNE ACTIVITÉ IMMUNOREGULATRICE, PROCÉDÉ POUR ISOLER CES POPULATIONS DE CELLULES, ET LEURS UTILISATIONS
German Title of Invention:
ZELLPOPULATIONEN MIT IMMUNOREGULIERENDER AKTIVITÄT, VERFAHREN ZUR ISOLIERUNG UND VERWENDUNG
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
03/12/2025
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Request Received
Unitary Effect Acceptance Decision Date:
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
Unitary Effect Registration Date:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
22/09/2006
Grant date:
05/11/2025
EP Publication Date:
06/07/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/11/2025
EP B1 Publication Date:
05/11/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/09/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/10/2025
 
 

Name:
Consejo Superior De Investigaciones Científicas
Address:
C/ Serrano 117, 28006 Madrid, Spain (ES)

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, Japan (JP)

Inventor

1

Name:
Delgado Mora, Mario
Address:
Spain (ES)

2

Name:
Büscher, Dirk
Address:
Spain (ES)

3

Name:
González de la Peña, Manuel Angel
Address:
Spain (ES)

Priority

Priority Number:
05077186
Priority Date:
23/09/2005
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 39/00; A61P 37/06; C12N 5/0775; C12N 5/071;

Publication

European Patent Bulletin

1

Issue number:
202545
Publication date:
05/11/2025
Description:
Grant (B1)

2

Issue number:
202602
Publication date:
07/01/2026
Description:
Unitary Effect Request Receipt
Filing date Document type Number of pages